Cargando...
The rationale for including immune checkpoint inhibition into multimodal primary treatment concepts of head and neck cancer
BACKGROUND: Treatment of locally advanced squamous cell carcinomas of the head and neck (SCCHN) remains unsatisfactory. Although the addition of concurrent radiochemotherapy (RCT) or the combination of radiotherapy with blockade of the epidermal growth factor receptor (EGFR) have improved outcomes o...
Gardado en:
| Publicado en: | Cancers Head Neck |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
BioMed Central
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6460729/ https://ncbi.nlm.nih.gov/pubmed/31093338 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s41199-016-0009-6 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|